Futura Medical (FUM) Competitors

Futura Medical (LON:FUM) and Verseon (LON:VSN) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, media sentiment, valuation, dividends, risk and profitability.

Do insiders and institutionals hold more shares of FUM or VSN?

35.7% of Futura Medical shares are held by institutional investors. 32.1% of Futura Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Is FUM or VSN more profitable?

Verseon has a net margin of 0.00% compared to Futura Medical's net margin of -44.64%. Verseon's return on equity of 0.00% beat Futura Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Futura Medical	-44.64%	-56.44%	-26.59%
Verseon	N/A	N/A	N/A

Which has preferable earnings & valuation, FUM or VSN?

Verseon has lower revenue, but higher earnings than Futura Medical. Futura Medical is trading at a lower price-to-earnings ratio than Verseon, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Futura Medical	£8.68M	3.23	-£3.88M	-£1.21	-7.42
Verseon	N/A	N/A	N/A	-£14.30	N/A

Does the media favor FUM or VSN?

In the previous week, Futura Medical had 1 more articles in the media than Verseon. MarketBeat recorded 1 mentions for Futura Medical and 0 mentions for Verseon. Futura Medical's average media sentiment score of 0.00 equaled Verseon'saverage media sentiment score.

Company	Overall Sentiment
Futura Medical	Neutral
Verseon	Neutral

Summary

Futura Medical beats Verseon on 5 of the 9 factors compared between the two stocks.